Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:13:18.143Z.
Calculation as of: 2026-10-06T22:13:18.143Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87d00981f6afc2d6fb42b8babadf75d30967326f42a5e12d4c63051d6ceded83
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Atrium Therapeutics, Inc.
Market Cap
$136.67M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$136.57M
Operating Cash Flow Yield
N/A
TTM Avg
1.70%
3Y Avg
1.70%
5Y Avg
1.70%
Market Cap
$137.80M
Operating Cash Flow Yield
1.01%
TTM Avg
0.36%
3Y Avg
0.36%
5Y Avg
0.36%
Market Cap
$139.04M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.47M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.84M
Operating Cash Flow Yield
N/A
TTM Avg
1.60%
3Y Avg
1.60%
5Y Avg
3.36%
Market Cap
$132.03M
Operating Cash Flow Yield
N/A
TTM Avg
6.01%
3Y Avg
5.49%
5Y Avg
5.49%
Market Cap
$131.21M
Operating Cash Flow Yield
0.97%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | $136.67M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | N/A | 1.70% | 1.70% | 1.70% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 1.01% | 0.36% | 0.36% | 0.36% |
| Immuneering Corporation (IMRX)vs › | $139.04M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | N/A | 1.60% | 1.60% | 3.36% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 6.01% | 5.49% | 5.49% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.97% | 3.24% | 4.92% | 5.15% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 21.59% | 12.96% | 8.76% | 8.76% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
